182 related articles for article (PubMed ID: 2797641)
1. Mood and cognitive style in premenstrual syndrome.
Rapkin AJ; Chang LC; Reading AE
Obstet Gynecol; 1989 Oct; 74(4):644-9. PubMed ID: 2797641
[TBL] [Abstract][Full Text] [Related]
2. Cognitive flexibility, reaction time, and attention in women with premenstrual dysphoric disorder.
Morgan M; Rapkin A
J Gend Specif Med; 2002; 5(3):28-36. PubMed ID: 12078060
[TBL] [Abstract][Full Text] [Related]
3. Menstrual phase-independent retrieval deficit in women with PMS.
Keenan PA; Lindamer LA; Jong SK
Biol Psychiatry; 1995 Sep; 38(6):369-77. PubMed ID: 8547456
[TBL] [Abstract][Full Text] [Related]
4. [Influence of premenstrual syndrome and oral contraceptive effects on food choice during the follicular and luteal phase of the menstrual cycle].
Tucci SA; Murphy LE; Boyland EJ; Halford JC
Endocrinol Nutr; 2009 Apr; 56(4):170-5. PubMed ID: 19627733
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome.
Cubeddu A; Bucci F; Giannini A; Russo M; Daino D; Russo N; Merlini S; Pluchino N; Valentino V; Casarosa E; Luisi S; Genazzani AR
Psychoneuroendocrinology; 2011 May; 36(4):523-30. PubMed ID: 20933336
[TBL] [Abstract][Full Text] [Related]
6. Progesterone metabolite allopregnanolone in women with premenstrual syndrome.
Rapkin AJ; Morgan M; Goldman L; Brann DW; Simone D; Mahesh VB
Obstet Gynecol; 1997 Nov; 90(5):709-14. PubMed ID: 9351749
[TBL] [Abstract][Full Text] [Related]
7. The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls.
Nyberg S; Andersson A; Zingmark E; Wahlström G; Bäckström T; Sundström-Poromaa I
Psychoneuroendocrinology; 2005 Oct; 30(9):892-901. PubMed ID: 15979810
[TBL] [Abstract][Full Text] [Related]
8. Symptoms of depression in late luteal phase dysphoric disorder: a variant of mood disorder?
De Ronchi D; Ujkaj M; Boaron F; Muro A; Piselli M; Quartesan R
J Affect Disord; 2005 Jun; 86(2-3):169-74. PubMed ID: 15935236
[TBL] [Abstract][Full Text] [Related]
9. Negative cognitive styles as risk factors for the occurrence of PMS and PMDD.
Śliwerski A; Bielawska-Batorowicz E
J Reprod Infant Psychol; 2019 Jul; 37(3):322-337. PubMed ID: 30468400
[No Abstract] [Full Text] [Related]
10. Frontal EEG asymmetry and premenstrual dysphoric symptomatology.
Accortt EE; Allen JJ
J Abnorm Psychol; 2006 Feb; 115(1):179-84. PubMed ID: 16492109
[TBL] [Abstract][Full Text] [Related]
11. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).
Reed SC; Levin FR; Evans SM
Horm Behav; 2008 Jun; 54(1):185-93. PubMed ID: 18413151
[TBL] [Abstract][Full Text] [Related]
12. Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder.
Thys-Jacobs S; McMahon D; Bilezikian JP
Am J Obstet Gynecol; 2008 May; 198(5):506.e1-8. PubMed ID: 18199422
[TBL] [Abstract][Full Text] [Related]
13. Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486.
Chan AF; Mortola JF; Wood SH; Yen SS
Obstet Gynecol; 1994 Dec; 84(6):1001-5. PubMed ID: 7970453
[TBL] [Abstract][Full Text] [Related]
14. Depressive mood and frontal alpha asymmetry during the luteal phase in premenstrual dysphoric disorder.
Lin IM; Tsai YC; Peper E; Yen CF
J Obstet Gynaecol Res; 2013 May; 39(5):998-1006. PubMed ID: 23551544
[TBL] [Abstract][Full Text] [Related]
15. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
[TBL] [Abstract][Full Text] [Related]
16. [Mood changes and premenstrual syndrome].
Tanini N; Giardinelli L; Donati D; Guidoni G; Cabras P
Minerva Psichiatr; 1991; 32(4):211-20. PubMed ID: 1808432
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study.
Freeman EW; Sondheimer SJ; Rickels K; Albert J
J Clin Psychiatry; 1993 May; 54(5):192-5. PubMed ID: 8509350
[TBL] [Abstract][Full Text] [Related]
18. Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders.
Gonda X; Telek T; Juhász G; Lazary J; Vargha A; Bagdy G
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1782-8. PubMed ID: 18721843
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
Freeman EW; Sondheimer SJ; Rickels K
Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences.
Mortola JF; Girton L; Beck L; Yen SS
Obstet Gynecol; 1990 Aug; 76(2):302-7. PubMed ID: 2371035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
